CompaniesElsie Biotechnologies

Elsie Biotechnologies

defunct

About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (2)

Total Trials

2

As Lead Sponsor

0

As Collaborator

2

Total Enrollment

48

By Phase

PHASE2/PHASE3: 1PHASE1: 1

By Status

WITHDRAWN: 1COMPLETED: 1

Clinical Trials Pipeline2 trials

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2019

2020

2021

2022

2023

2024

2025

Today

Hover over trial bars to see details

Recent Trials

NCT05142527Collaborator

Study to Evaluate the Safety and Efficacy of a Monoclonal Antibody Cocktail for the Prevention of COVID-19

PHASE2/PHASE3Withdrawn

Started: Jan 31, 2023 · Completed: Apr 30, 2024

NCT04592549Collaborator

Study of Monoclonal Antibody Cocktail Being Tested for the Prevention of COVID-19

PHASE1Completed

48 participants

Started: Dec 4, 2020 · Completed: Oct 6, 2023

Related Companies

Gsk

acquired